Similarly, the AD biomarker-positive ADD and MCI groups both had significantly increased CSF Ng concentrations compared to the biomarker-negative group (p < 0.0001 for both) (Fig. 1c, d). This evidence concerns the gene NRGN and Alzheimer disease.